Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes

European Journal of Biochemistry

Volumn 252, Issue 1, 1998, Pages 140-146

  Vergote, Jackie ^a   Moretti, Jean Luc ^a   De Vries, Elisabeth G E ^b   Garnier Suillerot, Arlette ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Multidrug resistance; Multidrug resistance protein; P glycoprotein; Technetium hexakis(methoxyisobutylisonitrile)

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT; DAUNORUBICIN; GLYCOPROTEIN P; MEMBRANE PROTEIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CANCER; CELL STRAIN K 562; CONTROLLED STUDY; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; KINETICS; MICHAELIS CONSTANT; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPORT KINETICS;

EID: 0032519555     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2520140.x     Document Type: Article

References (49)

1. Bradley, G., Juranka, P. F. & Ling, V. (1988) Mechanism of multidrug-resistance, Biochim. Biophys. Acta 948, 87-128.
2. Broxterman, H. J., Schuurhuis, G. J., Lankelma, J., Oberink, J. W., Eekman, C. A., Claessen, A. M. E., Hoekman, K., Poot, M. & Pinedo, H. M. (1997) Highly sensitive and specific detection of P-glycoprotein function for hematological and solid tumour cells using a novel nucleic acid stain, Br. J. Cancer 76, 1029-1034.
3. Chernoff, D. M., Strichartz, G. R. & Piwnica-Worms, D. (1993) Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutylisonitrile)technetium(I), Biochim. Biophys. Acta 1147, 262-266.
4. Chiu, M. L., Kronauge, J. F. & Piwnica-Worms, D. (1990) Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis(2-methoxyisobutylisonitrile)technetium(I) in cultured mouse fibroblasts, J. Nucl. Med. 31, 1646-1653.
5. Cohen, L. B. & Salzberg, B. M. (1978) Optical measurement of membrane potential, Biochem. Pharmacol. 83, 35-88.
6. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V. & Deeley, R. G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science 258, 1650-1654.
7. Cole, S. P. C., Sparks, K. E., Fraser, L., Loe, D. W., Grant, C. E., Wilson, G. M. & Deeley, R. G. (1994) Pharmacological characterization of multidrug-resistant MRP-transfected human tumor cells, Cancer Res. 54, 5902-5910.
8. Cornwell, M. M., Tsuruo, T., Gottesman, M. M. & Pastan, I. (1987) ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells, FASEB J. 1, 51-54.
9. Davey, R. A., Longhurst, T. J., Davey, M. W., Belov, L., Harvie, R. M., Hancox, D. & Wheeler, H. (1995) Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line, Leukemia Res. 19, 275-282.
10. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J. & Chen, L. B. (1985) Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells, J. Biol. Chem. 260, 13844-13850.
11. Emaus, R. K., Grunwald, R. & Lemaster, J. J. (1986) Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties, Biochim. Biophys. Acta 850, 436-448.
12. Feller, N., Broxterman, H. J., Währer, D. C. R. & Pinedo, H. M. (1995) ATP-dependent efflux of calcein by the multidrug-resistance protein (MRP): no inhibition by intracellular glutathione depletion, FEBS Lett. 308, 385-388.
13. Ferrandis, H., Da Silva, J., Riou, J. & Benard, J. (1994) Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse, Cancer Res. 54, 2256-2261.
14. Fréard, F. & Garnier-Suillerot, A. (1991) Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells, Eur. J. Biochem. 196, 483-491.
15. Golstein, L. J., Fojo, A. T., Crist, W., Green, A., Brodeur, G., Pastan, I. & Gottesman, M. M. (1990) Expression of the multidrug-resistance, MDR1, gene in neuroblatomas, J. Clin. Oncol. 8, 128-136.
16. Gottesman, M. M. & Pastan, I. (1993) Biochemistry of multidrug-resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62, 385-427.
17. Grinus, L. L., Jasaitus, A. A., Kadziauskas, T. P., Liberman, E. A., Skulachev, V. P., Topali, V. P., Tsofina, L. M. & Valdimirova, E. A. (1970) Conversion of biomembrane produced energy into electrical form, Biochim. Biophys. Acta 216, 1-12.
18. Heijn, M., Hooijberg, J. H., Scheffer, G. L., Szabó, G., Westerhoff, H. V. & Lankelma, J. (1997). Anthracyclines modulate multidrug-resistance protein (MRP) mediated organic anion transport, Biochim. Biophys. Acta 1326, 12-22.
19. 99mTC-sestamibi accumulation in P-glycoprotein positive and MRP positive cell lines [Abstract], Proc. Am. Assoc. Cancer Res. 36, 358.
20. 99mTc-SES-TAMIBI is a substrate for P-glycoprotein and the multidrug resitance associated protein, Br. J. Cancer, in the press.
21. Heytler, P. G. (1979) Uncouplers of oxidative phosphorylation, Methods Enzymol. 55, 462-472.
22. Hill, T. (1985) Cooperative theory in biochemistry, pp. 63-67, Springer-Verlag, Berlin.
23. Horio, M., Gottesman, M. M. & Pastan, I. (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells, Proc. Natl Acad. Sci. USA 85, 3580-3584.
24. Hughes, A. L. (1994) Evolution of the ATP-binding cassette transmembrane transporters of vertebrates, Mol. Biol. Evol. 11, 899-910.
25. Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P. C., Deeley, R. G. & Keppler, D. (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates, J. Biol. Chem. 269, 27 807-27 810.
26. Litchstein, D., Kaback, H. R. & Blume, A. J. (1979) Use of a lipophilic cation for determination of membrane potential in neuroblastomaglioma hybrid cell suspensions, Proc. Natl Acad. Sci. USA 76, 650-654.
27. Loe, D. W., Deeley, R. G. & Cole, S. P C. (1996) Biology of the multidrug-resistance-associated protein, Eur. J. Cancer 32A, 945-957.
28. Lozio, C. B. & Lozio, B. B. (1975) Human chronic myelogeneous leukemia cell line positive Philadelphia chromosome, Blood 45, 321-334.
29. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982) Molecular cloning. A laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
30. Mankhetkorn, S., Dubru, F., Hesschenbrouck, J., Fiallo, M. & Garnier-Suillerot, A. (1996) Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells, Mol. Pharmcol. 49, 532-539.
31. Marbeuf-Gueye, C., Broxterman, H., Dubru, F., Priebe, W. & Garnier-Suillerot, A. (1998) Kinetics of anthracycline efflux from MRP-expressing, as compared with P-glycoprotein-expressing, cancer cells, Mol. Pharmacol., in the press.
32. McGrath, T., Latoud, C., Arnold, S. T., Safa, A. R., Felsted, R. L. & Center, M. S. (1989) Mechanisms of multidrug-resistance in HL-60 cells: analysis of resistance associated membrane proteins and levels of mdr gene expression, Biochem. Pharmacol. 38, 3611-3619.
33. Moretti, J. L., Calgar, M., Duran-Cordobes, M. & Morere, J. F. (1995) Can nuclear medicine predict response to chemotherapy? Eur. J. Nucl. Med. 22, 97-100.
34. Müller, M., Meijer, C., Zaman, G. J. R., Borst. P., Scheper, R. J., Mulder, N. H., de Vries, E. G. E. & Jansen, P. L. M. (1994) Overexpression of the gene encoding the multidrug-resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport, Proc. Natl Acad. Sci. USA 91, 13 033-13 037.
35. Pearce, H. L., Safa, A. R., Winter, N. J., Cirtain, M. C. & Beck, W. T. (1989) Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug-resistance, Proc. Natl Acad. Sci. USA 86, 5128-5132.
36. Piwnica-Worms, D, Jacob, R., Horres, C. R. & Lieberman, M. (1983) Transmembrane chloride flux in tissue-cultured chick heart cells, J. Gen. Physiol. 81, 731-748.
37. Piwnica-Worms, D. & Holman, B. L. (1990a) Noncardiac applications of hexakis(alkyisonitrile)technetium-99m complexes, J. Nucl. Med. 31, 1166-1167.
38. Piwnica-Worms, D., Kronauge, J. F. & Chiu, M. L. (1990b) Uptake and retention of hexakis(2-methoxyisobutylisonitrile)technetium(I) in cultured chick myocardial cells, Circulation 82, 1826-1838.
39. Piwnica-Worms, D, Chiu, M. L., Budding, M., Kronauge, J. F., Kramer, R. A. & Croop, J. M. (1993) Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex, Cancer Res. 53, 977-984.
40. Piwnica-Worms, D., Rao, V. V., Kronauge, J. F. & Croop, J. M. (1995) Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation, Biochemistry 34, 12 210-12 220.
41. Rao, V. V., Chiu, M. L., Kronauge, J. F. & Piwnica-Worms, D. (1994) Expression of recombinant human multidrug-resistance P-glycoprotein in insect cells confers decreased accumulation of technecium-99m-sestamibi, J. Nucl. Med. 35, 510-515.
42. Shen, H., Paul, S., Breuninger, L. M., Ciaccio, P. J., Laing, N. M., Helt, M., Tew, K. D. & Kruh, G. D. (1996) Cellular and in vitro transport of glutathione conjugates by MRP, Biochemistry 35, 5719-5725.
43. Tarasiuk, J., Frézard, F., Gattegno, L. & Garnier-Suillerot, A. (1989) Anthracycline incorporation in human lymphocytes. Kinetics of up-take and nuclear concentration, Biochim. Biophys. Acta 1013, 109-117.
44. Tsuruo, T., Iida, H., Kawataba, H., Oh-Hara, T., Hamada, H. & Utakoji, T. (1986) Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones, Jpn J. Cancer Res. 77, 682-687.
45. Twentyman, P. R., Rhodes, T. & Rayner, S. (1994) A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug-resistance phenotypes, Eur. J. Cancer 30A, 1360-1369.
46. Versantvoort, C. H. M., Broxterman, H. J., Bagrij, T., Scheper, R. J. & Twentyman, P. R. (1995a) Regulation by glutathione of drug transport in multidrug-resistant human tumour cell lines overexpressing MRP, Br. J. Cancer 72, 82-89.
47. Versantvoort, C. H. M., Withoff, S., Broxterman, H. J., Kuiper, C. M., Scheper. R. J., Mulder, N. H. & de Vries, E. G. E. (1995b) Resistance associated factors in human small cell lung carcinoma GLC4 sublines with increasing adriamycin resistance, Int. J. Cancer 61, 375-380.
48. Williams, J. A. (1970) Origin of transmembrane potentials in non-excitable cells, J. Theor. Biol. 28, 287-296.
49. Zijlstra, J. G., de Vries, E. G. E. & Mulder, N. H. (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line, Cancer Res. 47, 1780-1784.